A COMPARATIVE EVALUATION OF INTERLEUKIN-35 LEVELS IN CHRONIC PERIODONTITIS PATIENTS WITH AND WITHOUT TYPE 2 DIABETES MELLITUS AND ITS RESPONSE TO NONSURGICAL PERIODONTAL THERAPY- A CLINICO- BIOCHEMICAL STUDY

  • Gopiparthi Neeharika Sree
  • Jayasheela M
  • D. S. Mehta
  • vinayaka a m
Cite this:
[1]
G. N. . Sree, J. M, D. S. . Mehta, and vinayaka a m, “A COMPARATIVE EVALUATION OF INTERLEUKIN-35 LEVELS IN CHRONIC PERIODONTITIS PATIENTS WITH AND WITHOUT TYPE 2 DIABETES MELLITUS AND ITS RESPONSE TO NONSURGICAL PERIODONTAL THERAPY- A CLINICO- BIOCHEMICAL STUDY”, ijmhs, vol. 10, no. 10, pp. 1288–1295, Oct. 2020.
© 2022 Interactive Protocols
RIGHTS & PERMISSIONS
Article Views
301
Altmetric
1
Citations
-
LEARN ABOUT THESE METRICS
   PDF  

Abstract

Background:Periodontitis is an inflammatory condition of the tooth
supporting structures in which we can discover an imbalance of
cytokines. Interleukin-35 (IL-35) is an anti-inflammatory cytokine that
has been upregulated in chronic periodontitis. Since Diabetes Mellitus
is a systemic condition, where there will be a greater existence of
cytokine imbalance, hence the aim of the present study was to
investigate the role of Gingival Crevicular Fluid (GCF) IL-35 in
chronic periodontitis patients with Type 2 Diabetes Mellitus after
Scaling and Root Planing (SRP).
Materials and Methods: A total of 114 patients with an age range of
30-60 years, were divided into 3 groups: Group I (healthy patients),
Group II (chronic periodontitis), and Group III (chronic periodontitis
with Diabetes Mellitus). Subsequently a thorough Medical & Dental
history was recorded alongside the clinical parameters too and
followed by the collection of GCF samples to perform ELISA analysis
for the detection of IL-35. Latter, the SRP was carried out in Group II
& III with a follow up of 6 weeks. Again at the end of 6 weeks the
clinical parameters were recorded & GCF samples were collected to
perform ELISA analysis for the detection of IL-35.
Results: IL-35 levels were increased in GCF collected from Group II
& III compared to Group I. However, after Non-Surgical Periodontal
Therapy, there was reduction in the IL-35 levels in GCF collected
from Group II & III.
Conclusion: This study clinches that GCF IL-35 levels were higher in
Group II & Group III, which later reduced after SRP, suggesting that
the role of IL-35 in periodontal disease, hence it can be considered as
a Novel Diagnostic Biomarker in the diagnosis of periodontal disease.
KEY WORDS: Biomarker; Chronic periodontitis; Gingival
Crevicular Fluid; Interleukin-35; Type 2 Diabetes Mellitus.

KEYWORDS:

 Special Issue

Article Metrics Graph

Chart Graph | Range Graph

Content

Section

Source

License

All paper submissions must carry the following duly signed by all the authors:
“I certify that I have participated sufficiently in the conception and design of this work and the analysis of the data (wherever applicable), as well as the writing of the manuscript, to take public responsibility for it. I believe the manuscript represents valid work. I have reviewed the final version of the manuscript and approve it for publication. Neither has the manuscript nor one with substantially similar content under my authorship been published nor is being considered for publication elsewhere, except as described in an attachment. Furthermore I attest that I shall produce the data upon which the manuscript is based for examination by the editors or their assignees, if requested.”